ATAI Life Sciences AG

A biotechnology company pioneering mental health innovation

Launch date

Jun 2018

Employees

Ownership

public, angel, venture capital

Market cap

Net debt

-

Firm valuation

$2.6b (Public information from Nov 2021)

Berlin Berlin (HQ)

https://www.atai.life/

https://twitter.com/atai_life https://www.linkedin.com/company/atai-life-sciences

Revenues, earnings & profits over time

EUR	2016	2017	2018	2019	2020	2021	2022E
Revenues	-	-	1m	-	-	-	-
EBITDA	-	-	(2m)	-	-	-	-
% EBITDA margin	-	-	(200 %)	-	-	-	-

Date	Investors	Amount	Round
-	Q Capital Ventures	N/A	- Not yet verified
Jul 2018	N/A	$3.6m	Seed Not yet verified
Oct 2018	Mike Novogratz Thor Bjorgolfsson	$25m	Series A
Mar 2019	Apeiron Investment Group Subversive Capital	$43m	Series B
Oct 2019	N/A	N/A	Secondary Not yet verified
Apr 2020*	Peter Thiel Christian Angermayer Thor Bjorgolfsson Efrem Kamen	$24m	Convertible
Jul 2020	N/A	$8m	Convertible Not yet verified
Nov 2020	Alpha Wave Global Galaxy Investment Partners (Galaxy Digital) Apeiron Investment Group Pura Vida Investments Thiel Capital Future Ventures Catalio Capital Management Neo Kuma Ventures	$125m	Series C
Mar 2021	Alpha Wave Global Apeiron Investment Group Pura Vida Investments Thiel Capital Subversive Capital Fearless Ventures Catalio Capital Management Woodline Partners Highline Capital Management Neo Kuma Ventures	$157m Valuation: $2.0b	Series D
Jun 2021	N/A	$225m Valuation: $2.3b	IPO
Total Funding		$374m

Tech stackLearn more about the technologies and tools that this company uses.

COMPASS Pathways

exited

ACQUISITION by ATAI Life Sciences AG Apr 2021

Recognify Life Sciences

ACQUISITION by ATAI Life Sciences AG Jan 2021